Monash University, Melbourne, Australia
Professor Philip Bardin is a Professor of Lung and Sleep Medicine in the Faculty of Medicine, Monash University, Melbourne, Australia. Under his leadership over the last eight years, the department has more than tripled in size and has established effective infrastructure and lines of delegation. Philip is a clinician-scientist with a record of successful investigation in both clinical and laboratory domains and is recognised as an international expert in severe asthma, Chronic Obstructive Pulmonary Disease (COPD) and Vocal Cord Dysfunction (VCD). Investigations of new asthma and COPD therapies have been performed by the Lung Clinical Trials Unit established by Philip at Monash Lung and Sleep. He has participated in and taken a leadership role in numerous randomised controlled trials focused on severe asthma and COPD.
Philip is recognised for the investigation of obstructive lung diseases (particularly virus-asthma-COPD exacerbations) and has conducted extensive research on new asthma and COPD therapies. Recently his research has also focussed on VCD in obstructive lung diseases. Philip is a recipient of ongoing Australian National Health and Medical Research Council (NHMRC) funding, has chaired the Australian NHMRC Grant Review Panel (Respiratory and Sleep Medicine) and has served on the Australian NHMRC Academy. His professional activities reflect a career-long commitment to research and medical education, particularly in the areas of asthma and COPD. Currently, Philip is Editor-in-chief of Respirology; the official journal of the Thoracic Society of Australia and New Zealand and Asia Pacific Society of Respirology.
Role in Centre of Excellence in Treatable Traits